Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Defensin alpha 4 (DEFA4) is a human alpha-defensin peptide encoded by the DEFA4 gene, primarily found in the granules of neutrophils. It plays a key role in the innate immune response by exhibiting antimicrobial activity against Gram-negative bacteria, to a lesser extent also against Gram-positive bacteria and some fungi. DEFA4 can also interact with certain pathogen proteins, such as HIV-1 gp120 and anthrax lethal factor. Additionally, it displays corticostatic activity, inhibiting ACTH-stimulated corticosteroid production. Expression patterns and mRNA levels of DEFA4 may have clinical significance as biomarkers in diseases such as chronic myeloid leukemia[1][2][6][8].
Disruption of microbial membranes (antimicrobial); Inhibition of pathogen virulence factors (such as HIV-1 gp120 and anthrax lethal factor); Inhibition of hormone-stimulated steroidogenesis (corticostatin activity)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Defensin alpha 4 (DEFA4).